These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 1846814

  • 21. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
    Costello R, Cerdan C, Pavon C, Brailly H, Hurpin C, Mawas C, Olive D.
    Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
    [Abstract] [Full Text] [Related]

  • 22. CD44 contributes to T cell activation.
    Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A.
    J Immunol; 1989 Aug 01; 143(3):798-801. PubMed ID: 2568380
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA, Kanner SB, Schieven GL, Thompson CB, Ledbetter JA.
    Eur J Immunol; 1992 Feb 01; 22(2):551-7. PubMed ID: 1371471
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Induction of T cell CD7 gene transcription by nonmitogenic ionomycin-induced transmembrane calcium flux.
    Ware RE, Hart MK, Haynes BF.
    J Immunol; 1991 Oct 15; 147(8):2787-94. PubMed ID: 1717576
    [Abstract] [Full Text] [Related]

  • 28. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.
    Gruters RA, Terpstra FG, De Jong R, Van Noesel CJ, Van Lier RA, Miedema F.
    Eur J Immunol; 1990 May 15; 20(5):1039-44. PubMed ID: 2162775
    [Abstract] [Full Text] [Related]

  • 29. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH, Ledbetter JA, Lindsten T, Thompson CB.
    J Immunol; 1989 Jul 01; 143(1):153-61. PubMed ID: 2543699
    [Abstract] [Full Text] [Related]

  • 30. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways.
    Mor-Vaknin N, Torgeman A, Galron D, Löchelt M, Flügel RM, Aboud M.
    Virology; 1997 Jun 09; 232(2):337-44. PubMed ID: 9191847
    [Abstract] [Full Text] [Related]

  • 31. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R, Cerdan C, Lipcey C, Algarté M, Martin Y, Baeuerle PA, Olive D, Imbert J.
    Cell Growth Differ; 1993 Nov 09; 4(11):947-54. PubMed ID: 7905283
    [Abstract] [Full Text] [Related]

  • 32. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
    Pierres A, Cerdan C, Lopez M, Mawas C, Olive D.
    J Immunol; 1990 Feb 15; 144(4):1202-7. PubMed ID: 1968076
    [Abstract] [Full Text] [Related]

  • 33. Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells.
    Granelli-Piperno A, Nolan P.
    J Immunol; 1991 Oct 15; 147(8):2734-9. PubMed ID: 1655897
    [Abstract] [Full Text] [Related]

  • 34. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
    Oshima S, Eckels DD.
    J Immunol; 1990 Dec 15; 145(12):4018-25. PubMed ID: 1979584
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes.
    Bressler P, Pantaleo G, Demaria A, Fauci AS.
    J Immunol; 1991 Oct 01; 147(7):2290-4. PubMed ID: 1680914
    [Abstract] [Full Text] [Related]

  • 37. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.
    Israël N, Hazan U, Alcami J, Munier A, Arenzana-Seisdedos F, Bachelerie F, Israël A, Virelizier JL.
    J Immunol; 1989 Dec 15; 143(12):3956-60. PubMed ID: 2574206
    [Abstract] [Full Text] [Related]

  • 38. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation.
    Pierrès A, Lopez M, Cerdan C, Nunes J, Olive D, Mawas C.
    Eur J Immunol; 1988 May 15; 18(5):685-90. PubMed ID: 2454190
    [Abstract] [Full Text] [Related]

  • 39. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H, Aubry JP, de Waal Malefijt R, de Vries JE, Spits H.
    J Immunol; 1987 Nov 01; 139(9):2850-5. PubMed ID: 2444643
    [Abstract] [Full Text] [Related]

  • 40. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies.
    Van Lier RA, Brouwer M, Aarden LA.
    Eur J Immunol; 1988 Jan 01; 18(1):167-72. PubMed ID: 3126073
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.